 |
Eric Chen | |
|---|---|
 | |
| Born | August 28, 1998 China |
| Education | New York University |
| Occupations | Entrepreneur, blockchain developer |
| Known for | Co-founder and CEO of Injective Labs |
Eric Chen is an entrepreneur and blockchain developer. He is the co-founder and chief executive officer of Injective Labs, a blockchain technology company focused on decentralized finance.
Chen studied business and computer science at New York University (NYU). In a 2025 first-person account published by Business Insider, Chen described taking a leave of absence from the university in 2018 to pursue Injective. He subsequently left NYU without completing his degree.
In 2018, Chen and Albert Chon co-founded Injective Labs. In a 2025 interview with Inc., Chen described an email pitch to Mark Cuban that preceded Cuban's investment in Injective in 2021.
In 2018, Injective received $500,000 through the incubation program of Binance Labs, later renamed YZi Labs.
In July 2020, Injective announced a $2.6 million seed funding round led by Pantera Capital. Other participants included QCP Soteria, Axia8 Ventures, Boxone Ventures and Bitlink Capital.
In April 2021, Injective announced a $10 million private token sale that included Cuban and Pantera Capital.
In August 2022, Injective announced a $40 million private token sale led by Jump Crypto.
In 2026, Chen co-authored a paper with Petar Zhivkov in the journal Mathematics on transaction fee mechanisms for blockchains with block times below one second.
Chen and Chon were named to the Forbes 30 Under 30 Finance list for 2024 for their work on Injective.
Chen has been profiled by Fortune and interviewed by Business Insider and Inc. He has also been covered by Benzinga.
Fortune has quoted Chen on prediction markets, CNBC on pre-IPO trading, and The Block on tokenized equities.
Chen has appeared on CNBC's Crypto World and Schwab Network's The Watch List.